Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations

Overview

Journal Curr Dermatol Rep

Specialty Dermatology

Date 2014 Mar 4

PMID 24587976

Citations 71

Authors

Shalini V Mohan

Anne Lynn S Chang

Affiliations

Soon will be listed here.

Abstract

Advanced basal cell carcinomas are a subset of basal cell carcinomas that can be difficult to treat either due to their local invasiveness, proximity to vital structures, or metastasis. The incidence of all basal cell carcinoma is increasing in the United States, although it is not known whether advanced basal cell carcinomas (aBCCs) are also increasing. Recently, highly targeted therapy based on knowledge of the basal cell carcinoma pathogenesis has become available either commercially or through human clinical trials. These orally available drugs inhibit the Hedgehog signaling pathway, and lead to advanced basal cell carcinoma shrinkage that can enable preservation of adjacent vital organs. In this review, we outline the role of Hedgehog pathway inhibitors as well as other treatment modalities such as excision, radiotherapy and more traditional chemotherapy in treating advanced basal cell carcinomas. We also highlight current gaps in knowledge regarding the use and side effects of this targeted therapy.

Citing Articles

A recent update on the connection between dietary phytochemicals and skin cancer: emerging understanding of the molecular mechanism.

Singh H, Mishra A, Mohanto S, Kumar A, Mishra A, Amin R Ann Med Surg (Lond). 2024; 86(10):5877-5913.

PMID: 39359831 PMC: 11444613. DOI: 10.1097/MS9.0000000000002392.

Is a 3 mm Surgical Margin Safe for Basal Cell Carcinoma in the Head and Neck that is Less than 2 cm, Considering Different Risk Factors?.

Yong M, Yoo S, Shin H Arch Plast Surg. 2024; 51(5):487-494.

PMID: 39345996 PMC: 11436326. DOI: 10.1055/a-2338-9192.

Retrospective Analysis of Clinicopathological Characteristics of Surgically Treated Basal Cell Carcinomas of the Face: A Single-Centre Maxillofacial Surgery Experience.

Saeidi A, Gulses A, Jamil M, Alolayan A, Elsayed S, Wiltfang J J Clin Med. 2024; 13(18).

PMID: 39336956 PMC: 11432292. DOI: 10.3390/jcm13185470.

Therapeutic Advances in Advanced Basal Cell Carcinoma.

Alkassis S, Shatta M, Wong D Cancers (Basel). 2024; 16(17).

PMID: 39272933 PMC: 11394629. DOI: 10.3390/cancers16173075.

Dermoscopy-based Radiomics Help Distinguish Basal Cell Carcinoma and Actinic Keratosis: A Large-scale Real-world Study Based on a 207-combination Machine Learning Computational Framework.

Guan H, Yuan Q, Lv K, Qi Y, Jiang Y, Zhang S J Cancer. 2024; 15(11):3350-3361.

PMID: 38817855 PMC: 11134443. DOI: 10.7150/jca.94759.

References

Jimeno A, Weiss G, Miller Jr W, Gettinger S, Eigl B, Chang A . Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors. Clin Cancer Res. 2013; 19(10):2766-74. PMC: 3694426. DOI: 10.1158/1078-0432.CCR-12-3654. View

Taipale J, Beachy P . The Hedgehog and Wnt signalling pathways in cancer. Nature. 2001; 411(6835):349-54. DOI: 10.1038/35077219. View

Aszterbaum M, Rothman A, Johnson R, Fisher M, Xie J, Bonifas J . Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol. 1998; 110(6):885-8. DOI: 10.1046/j.1523-1747.1998.00222.x. View

Xie J, Murone M, Luoh S, Ryan A, Gu Q, Zhang C . Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature. 1998; 391(6662):90-2. DOI: 10.1038/34201. View

Hall V, Leppard B, McGill J, Kesseler M, White J, Goodwin P . Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol. 1986; 37(1):33-4. DOI: 10.1016/s0009-9260(86)80161-1. View

Avril M, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E . Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer. 1997; 76(1):100-6. PMC: 2223779. DOI: 10.1038/bjc.1997.343. View

Soleymani A, Scheinfeld N, Vasil K, Bechtel M . Metastatic basal cell carcinoma presenting with unilateral upper extremity edema and lymphatic spread. J Am Acad Dermatol. 2008; 59(2 Suppl 1):S1-3. DOI: 10.1016/j.jaad.2007.08.041. View

Li Z, Mack S, Mak T, Angers S, Taylor M, Hui C . Evasion of p53 and G2/M checkpoints are characteristic of Hh-driven basal cell carcinoma. Oncogene. 2013; 33(20):2674-80. DOI: 10.1038/onc.2013.212. View

Shingler S, Garside J, Samanta K, Lear J, Keohane S, Lloyd A . Utilities for advanced basal cell carcinoma. J Med Econ. 2013; 16(6):777-83. DOI: 10.3111/13696998.2013.800822. View

10.

Wysong A, Aasi S, Tang J . Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol. 2013; 149(5):615-6. DOI: 10.1001/jamadermatol.2013.3064. View

11.

Moser S, Borm J, Mihic-Probst D, Jacobsen C, Kruse Gujer A . Metastatic basal cell carcinoma: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 117(2):e79-82. DOI: 10.1016/j.oooo.2012.04.030. View

12.

Tang J, Mackay-Wiggan J, Aszterbaum M, Yauch R, Lindgren J, Chang K . Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med. 2012; 366(23):2180-8. PMC: 4362529. DOI: 10.1056/NEJMoa1113538. View

13.

Weinstock M, Fisher D . Indoor ultraviolet tanning: what the data do and do not show regarding risk of melanoma and keratinocyte malignancies. J Natl Compr Canc Netw. 2010; 8(8):867-72. DOI: 10.6004/jnccn.2010.0063. View

14.

Koh D, Wang H, Lee J, Chia K, Lee H, Goh C . Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. Br J Dermatol. 2003; 148(6):1161-6. DOI: 10.1046/j.1365-2133.2003.05223.x. View

15.

Wu T, Stein J . Nonmelanoma skin cancer in young women. J Drugs Dermatol. 2013; 12(5):568-72. View

16.

Epstein E . Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008; 8(10):743-54. PMC: 4457317. DOI: 10.1038/nrc2503. View

17.

Sekulic A, Mangold A, Northfelt D, LoRusso P . Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway. Curr Opin Oncol. 2013; 25(3):218-23. DOI: 10.1097/CCO.0b013e32835ff438. View

18.

Amin S, Tibes R, Kim J, Hybarger C . Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma. Laryngoscope. 2010; 120(12):2456-9. DOI: 10.1002/lary.21145. View

19.

Almquist L, Karagas M, Christensen B, Welsh M, Perry A, Storm C . The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer. Carcinogenesis. 2010; 32(3):327-30. PMC: 3105583. DOI: 10.1093/carcin/bgq256. View

20.

Skvara H, Kalthoff F, Meingassner J, Wolff-Winiski B, Aschauer H, Kelleher J . Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor. J Invest Dermatol. 2011; 131(8):1735-44. DOI: 10.1038/jid.2011.48. View